Pharmacodynamic modeling of adverse effects of anti-cancer drug treatment

Area of Science:

• Pharmacology
• Mathematical Modeling
• Oncology

Background:

• Adverse effects of anti-cancer drugs significantly impact patient quality of life and treatment outcomes.
• Quantitative models are crucial for understanding the relationship between drug exposure and adverse event dynamics.
• Optimizing anti-cancer drug dosing regimens is essential for effective treatment and patient well-being.

Purpose of the Study:

• To review and provide a perspective on the methodologies used for modeling anti-cancer drug adverse effects.
• To present various model structures that describe the relationship between drug concentrations and toxicities.
• To highlight the clinical applicability of these quantitative models.

Main Methods:

• A comprehensive review of various quantitative pharmacodynamic models was conducted.
• The focus was on models specifically designed to describe adverse effects associated with anti-cancer drug treatments.
• Existing literature on pharmacodynamic modeling of anti-cancer drug toxicities was analyzed.

Main Results:

• Quantitative models have been developed for diverse anti-cancer agents, linking drug exposure to myelosuppression and cardiotoxicity.
• Models for graded adverse effects such as fatigue, hand-foot syndrome (HFS), rash, and diarrhea were presented.
• The clinical applicability and utility of these models in managing anti-cancer therapy were demonstrated.

Conclusions:

• Mathematical modeling of adverse effects is a valuable tool for enhancing clinical management and decision-making in drug development.
• The established models serve as templates for predicting and managing various anti-cancer-induced adverse effects.
• Optimizing anti-cancer therapy through informed dosing regimens can be significantly improved by utilizing these modeling approaches.